THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
Strontium ranelate (SR) that has a proven efficacy in reducing the risk of fractures and in increasing bone mineral density is currently recommended as a second choice drug for the treatment of severe osteoporosis (OP) in postmenopausal women and elderly men. Subjects and methods. In 2014–2015, a su...
| Autores principales: | , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Russian |
| Publicado: |
IMA PRESS LLC
2018-09-01
|
| Colección: | Научно-практическая ревматология |
| Materias: | |
| Acceso en línea: | https://rsp.mediar-press.net/rsp/article/view/2587 |